Gaudium IVF And Women Health (NSE:GAUDIUMIVF) Altman Z2-Score: 6.02 (As of Jul. 19, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GAUDIUMIVF Gaudium IVF And Women Health Ltd NSE:GAUDIUMIVF
20 GF Score
Price ₹143.78
! 5 Warning Signs
View Full Analysis

What is Gaudium IVF And Women Health Altman Z2-Score?

Gaudium IVF And Women Health NSE:GAUDIUMIVF +4.99% 20 Altman Z2-Score is 6.02 as of Jul. 19, 2026, which is 6% below its 10-year median of 6.38. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks better than 80.71% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Gaudium IVF And Women Health has a Altman Z2-Score of 6.02, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Gaudium IVF And Women Health's Altman Z2-Score or its related term are showing as below:

NSE:GAUDIUMIVF' s Altman Z2-Score Range Over the Past 10 Years
Min: 3.92   Med: 6.38   Max: 10.2
Current: 6.02

During the past 5 years, Gaudium IVF And Women Health's highest Altman Z2-Score was 10.20. The lowest was 3.92. And the median was 6.38.


Gaudium IVF And Women Health  (NSE:GAUDIUMIVF) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Gaudium IVF And Women Health Altman Z2-Score Related Terms


Gaudium IVF And Women Health Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Gaudium IVF And Women Health's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gaudium IVF And Women Health Altman Z2-Score Chart

Gaudium IVF And Women Health Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Altman Z2-Score
10.20 8.66 6.38 3.92 6.02

Gaudium IVF And Women Health Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only 0.00 3.92 5.45 0.00 6.02

NSE:GAUDIUMIVF vs HCA, THC, DVA: Altman Z2-Score Comparison

For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaudium IVF And Women Health Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Gaudium IVF And Women Health's Altman Z2-Score falls into.


NSE:GAUDIUMIVF
20GF Score
Gaudium IVF And Women Health Ltd NSE:GAUDIUMIVF
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gaudium IVF And Women Health Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Gaudium IVF And Women Health's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.1801+3.26*0+6.72*0.137+1.05*3.7327
=6.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was ₹1,931.0 Mil.
Total Current Assets was ₹733.0 Mil.
Total Current Liabilities was ₹385.3 Mil.
Retained Earnings was ₹0.0 Mil.
Pre-Tax Income was 104.222 + 49.631 + 0 + 81.569 = ₹235.4 Mil.
Interest Expense was -12.903 + -11.97 + 0 + -4.344 = ₹-29.2 Mil.
Total Liabilities was ₹408.0 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(733.02 - 385.273)/1931.045
=0.1801

X2=Retained Earnings/Total Assets
=0/1931.045
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(235.422 - -29.217)/1931.045
=0.137

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1523.021 - 0)/408.024
=3.7327

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Gaudium IVF And Women Health has a Altman Z2-Score of 6.02 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 6.02 mean?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a Altman Z2-Score of 6.02 as of Jul. 19, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Gaudium IVF And Women Health and its competitors. This is near median its historical median of 6.38. Over the past decade, Gaudium IVF And Women Health's Altman Z2-Score has ranged from 3.92 to 10.20. According to the industry distribution chart, Gaudium IVF And Women Health ranks #130 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 19.3%.
Is Gaudium IVF And Women Health's Altman Z2-Score too high?
Gaudium IVF And Women Health's current Altman Z2-Score of 6.02 is near median its 10-year median of 6.38. Over the past 10 years, this metric has ranged from a low of 3.92 to a high of 10.20. The Healthcare Providers & Services industry median Altman Z2-Score is 2.21. Gaudium IVF And Women Health's value of 6.02 is 173% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #130 out of 674 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #130 out of 674 companies for Altman Z2-Score. This places Gaudium IVF And Women Health in the top 19% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 2.21. Gaudium IVF And Women Health's value of 6.02 is 173% above this benchmark. Historically, Gaudium IVF And Women Health's own Altman Z2-Score has ranged from 3.92 to 10.20 over the past decade. While the company's 10-year median is 6.38 vs. the industry median of 2.21, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.21, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current Altman Z2-Score of 6.02 is 173% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current Altman Z2-Score is 6.02, which is near median its own 10-year median of 6.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current Altman Z2-Score of 6.02. The current Altman Z2-Score is 6.02, which is near median its 10-year median of 6.38 and 173% above the Healthcare Providers & Services industry median of 2.21. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current Altman Z2-Score is 6.02 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gaudium IVF And Women Health Business Description

Other Exchanges 544709:India
Address B1/51, Janak Puri, B-1, Near Janakpuri East Metro Station, New Delhi, IND, 110058
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score

Get the complete analysis for NSE:GAUDIUMIVF

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹143.78
Price